𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma

✍ Scribed by N. K. Minkov; B. I. Zozikov; Z. Yaneva; P. A. Uldry

Book ID
110335241
Publisher
Springer Netherlands
Year
2001
Tongue
English
Weight
66 KB
Volume
33
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Luteinizing hormone-releasing hormone ag
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma: A prospective double blind randomized trial
✍ GΓΌnter Emons; Olaf Ortmann; Hanns-Martin Teichert; Horst Fassl; Udo LΓΆhrs; Stig πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 908 KB

## Background: Several lines of evidence suggest that the proliferation of ovarian carcinoma might be stimulated by gonadotrophins. a number of phase i/phase ii clinical trials have reported that the suppression of endogenous luteinizing hormone and follicle-stimulating hormone secretion by luteini

A Phase II trial of green tea in the tre
A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
✍ Aminah Jatoi; Neil Ellison; Patrick A. Burch; Jeff A. Sloan; Shaker R. Dakhil; P πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Background: Recent laboratory and epidemiologic studies have suggested that green tea has antitumor effects in patients with prostate carcinoma. this phase ii trial explored green tea's antineoplastic effects in patients with androgen independent prostate carcinoma. ## Methods: This study, whi